Banga Puneet K, Singh Dhananjay K, Dadu Shalini, Singh Meenakshi
Department of Anesthesiology and Critical Care, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India.
Department of Community Medicine, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India.
Saudi J Anaesth. 2015 Apr-Jun;9(2):179-83. doi: 10.4103/1658-354X.152878.
In patients with penetrating eye injury and a full stomach, suxamethonium is still used for rapid sequence induction of anesthesia. But its use is associated with the rise in intraocular pressure (IOP) and this can result in permanent vision loss in these patients. Dexmedetomidine and clonidine are two alpha-2 adrenergic agonist drugs which prevent the rise in IOP. The aim of this study is to compare the efficacy of intravenous (i.v.) dexmedetomidine and clonidine in preventing an increase in IOP after administration of suxamethonium and tracheal intubation.
Sixty patients undergoing elective nonophthalmic surgery under general anesthesia were included in this clinical study. Patients were randomly assigned into three groups to receive 0.5 mcg/kg dexmedetomidine (Group D), 2 mcg/kg clonidine (Group C) or normal saline (Group S) as premedication i.v. over a period of 10 min before induction. IOP, heart rate, and mean arterial pressure were recorded before and after premedication, after suxamethonium, after intubation and then after 5 min.
Following administration of dexmedetomidine and clonidine IOP decreased in both groups. After suxamethonium IOP increased in all three groups but it never crossed the baseline in Group D and C. After laryngoscopy and intubation IOP again increased in all three groups but in dexmedetomidine group it never crossed the baseline whereas in clonidine group it was significantly higher than the baseline.
Single i.v. dose of dexmedetomidine premedication (0.5 mcg/kg) blunt the IOP and hemodynamic response to suxamethonium injection and tracheal intubation more effectively than single i.v. dose of clonidine premedication (2 mcg/kg).
在有穿透性眼外伤且胃内容物饱满的患者中,琥珀胆碱仍用于快速顺序诱导麻醉。但其使用与眼内压(IOP)升高有关,这可能导致这些患者永久性视力丧失。右美托咪定和可乐定是两种可预防IOP升高的α-2肾上腺素能激动剂药物。本研究的目的是比较静脉注射右美托咪定和可乐定在预防琥珀胆碱给药和气管插管后IOP升高方面的疗效。
本临床研究纳入了60例在全身麻醉下接受择期非眼科手术的患者。患者被随机分为三组,在诱导前10分钟内静脉注射0.5μg/kg右美托咪定(D组)、2μg/kg可乐定(C组)或生理盐水(S组)作为术前用药。在术前用药前、琥珀胆碱给药后、插管后以及5分钟后记录IOP、心率和平均动脉压。
右美托咪定和可乐定给药后两组的IOP均降低。琥珀胆碱给药后三组的IOP均升高,但D组和C组未超过基线水平。喉镜检查和插管后三组的IOP再次升高,但右美托咪定组未超过基线水平,而可乐定组显著高于基线水平。
单次静脉注射剂量的右美托咪定(0.5μg/kg)术前用药比单次静脉注射剂量的可乐定(2μg/kg)术前用药更有效地抑制了琥珀胆碱注射和气管插管引起的IOP和血流动力学反应。